Old Web
English
Sign In
Acemap
>
authorDetail
>
Tobias E Larsson
Tobias E Larsson
Center for Global Development
Albuminuria
Renal function
Medicine
Type 2 diabetes
Kidney disease
3
Papers
21
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Population pharmacokinetics and pharmacodynamics of a novel vascular adhesion protein-1 inhibitor using a multiple-target mediated drug disposition model.
2020
Journal of Pharmacokinetics and Pharmacodynamics
Nelleke Snelder
Sven Hoefman
Alberto Garcia-Hernandez
Hartmut Onkels
Tobias E Larsson
Kirsten Riber Bergmann
Show All
Source
Cite
Save
Citations (1)
Mechanism-based modeling of the effect of a novel inhibitor of vascular adhesion protein-1 on albuminuria and renal function markers in patients with diabetic kidney disease.
2020
Journal of Pharmacokinetics and Pharmacodynamics
Sven Hoefman
Nelleke Snelder
Martijn van Noort
Alberto Garcia-Hernandez
Hartmut Onkels
Tobias E Larsson
Kirsten Riber Bergmann
Show All
Source
Cite
Save
Citations (2)
Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial
2018
The Lancet Diabetes & Endocrinology
Dick de Zeeuw
Ronny W. Renfurm
George L. Bakris
Peter Rossing
Vlado Perkovic
Fan Fan Hou
Masaomi Nangaku
Kumar Sharma
Hiddo J. Lambers-Heerspink
Alberto Garcia-Hernandez
Tobias E Larsson
Show All
Source
Cite
Save
Citations (18)
1